105 related articles for article (PubMed ID: 6134631)
21. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils.
Nakashima S; Suganuma A; Sato M; Tohmatsu T; Nozawa Y
J Immunol; 1989 Aug; 143(4):1295-302. PubMed ID: 2545786
[TBL] [Abstract][Full Text] [Related]
22. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils.
Chen LW; Lin MW; Hsu CM
J Biomed Sci; 2005; 12(2):311-9. PubMed ID: 15917990
[TBL] [Abstract][Full Text] [Related]
23. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass.
Hoshikawa-Fujimura AY; Auler Júnior JO; Da Rocha TR; Brandizzi LI; Pascual JM; Chamone DA; Jatene AD
Braz J Med Biol Res; 1989; 22(9):1077-82. PubMed ID: 2561459
[TBL] [Abstract][Full Text] [Related]
24. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils.
Ikemura T; Manabe H; Sasaki Y; Ishii H; Onuma K; Miki I; Kase H; Sato S; Kitamura S; Ohmori K
Int Arch Allergy Immunol; 1996 May; 110(1):57-63. PubMed ID: 8645979
[TBL] [Abstract][Full Text] [Related]
25. The role of extracellular Ca2+ and Na+ in paf-acether-induced human platelet activation.
Keraly CL; Delautier D; Benveniste J
Biochem Pharmacol; 1989 Oct; 38(20):3415-21. PubMed ID: 2818633
[TBL] [Abstract][Full Text] [Related]
26. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function.
Dent G; Ukena D; Chanez P; Sybrecht G; Barnes P
FEBS Lett; 1989 Feb; 244(2):365-8. PubMed ID: 2537761
[TBL] [Abstract][Full Text] [Related]
27. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
[TBL] [Abstract][Full Text] [Related]
28. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
[TBL] [Abstract][Full Text] [Related]
29. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages.
Nakamura T; Nishizawa Y; Sato T; Yamato C
Eur J Pharmacol; 1988 Mar; 148(1):35-41. PubMed ID: 2898372
[TBL] [Abstract][Full Text] [Related]
30. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; Goldman DW; Chilton FH
Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
[TBL] [Abstract][Full Text] [Related]
31. Platelet-activating factor as a stimulus of exocytosis in human neutrophils.
Dewald B; Baggiolini M
Biochim Biophys Acta; 1986 Aug; 888(1):42-8. PubMed ID: 3017443
[TBL] [Abstract][Full Text] [Related]
32. Transient increase of cytosolic free calcium in cultured human vascular endothelial cells by platelet-activating factor.
Hirafuji M; Maeyama K; Watanabe T; Ogura Y
Biochem Biophys Res Commun; 1988 Aug; 154(3):910-7. PubMed ID: 3408504
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of mediator release from human basophils induced by platelet-activating factor.
Columbo M; Casolaro V; Warner JA; MacGlashan DW; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1990 Dec; 145(11):3855-61. PubMed ID: 1700998
[TBL] [Abstract][Full Text] [Related]
34. Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys.
Pirotzky E; Bidault J; Burtin C; Gubler MC; Benveniste J
Kidney Int; 1984 Feb; 25(2):404-10. PubMed ID: 6144811
[TBL] [Abstract][Full Text] [Related]
35. L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
Oshiro H; Kobayashi I; Kim D; Takenaka H; Hobson RW; Durán WN
J Vasc Surg; 1995 Dec; 22(6):732-9; discussion 739-41. PubMed ID: 8523608
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF.
Flamand N; Lefebvre J; Lapointe G; Picard S; Lemieux L; Bourgoin SG; Borgeat P
J Leukoc Biol; 2006 May; 79(5):1043-51. PubMed ID: 16501051
[TBL] [Abstract][Full Text] [Related]
37. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
38. Nifedipine impairs neutrophil respiratory burst by a mechanism other than calcium channel blockade.
Nalini K; Andrabi KI; Ganguly NK; Wahi PL
Mol Cell Biochem; 1990 Mar; 93(1):27-34. PubMed ID: 2158619
[TBL] [Abstract][Full Text] [Related]
39. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics.
Arnoux B; Joseph M; Simoes MH; Tonnel AB; Duroux P; Capron A; Benveniste J
Bull Eur Physiopathol Respir; 1987; 23(2):119-24. PubMed ID: 3607326
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human neutrophil function by tolfenamic acid involves inhibition of Ca2+ influx.
Kankaanranta H; Wuorela H; Siltaloppi E; Vuorinen P; Vapaatalo H; Moilanen E
Eur J Pharmacol; 1995 Sep; 291(1):17-25. PubMed ID: 8549643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
